EP1179990A1 - System and method for predicting disease onset - Google Patents
System and method for predicting disease onsetInfo
- Publication number
- EP1179990A1 EP1179990A1 EP00921448A EP00921448A EP1179990A1 EP 1179990 A1 EP1179990 A1 EP 1179990A1 EP 00921448 A EP00921448 A EP 00921448A EP 00921448 A EP00921448 A EP 00921448A EP 1179990 A1 EP1179990 A1 EP 1179990A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- disease
- disease prediction
- factors
- equation
- prediction factors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/923—Computer assisted medical diagnostics by comparison of patient data to other data
Definitions
- the present invention relates to predicting disease onset. More particularly, the present invention relates to using the combined contribution of multiple disease factors to predict onset of a particular disease in an individual wherein the contributions are obtained from separate studies.
- Y a + ⁇ b, X, (I)
- Y disease outcome (e.g., the probability of getting coronary heart disease); the constant "a" represents the disease outcome level when all disease prediction factors are equal to zero; X, represents the disease prediction factor (e.g., smoking, drinking, blood pressure, cholesterol levels, etc.); and b congestion the partial regression coefficient, represents how much each factor contributes to disease outcome.
- the partial regression coefficient may be viewed as a weighting factor. This process may be performed to diagnose the existence of a current disease as well as to predict future disease onset. Many studies of this kind have been carried out in the last decade or so.
- the Framingham Heart Disease Study which started in the 1960's and is still on-going, involves two generations of study participants that total roughly 6000 subjects.
- One of the publications of this study is reported in eaven Anderson et al., "An Updated Coronary Risk Profile — A Statement for Health Professionals” , Circulation 83:356-62 (1991), and is incorporated by reference in its entirety. These types of studies have provided some helpful disease prediction tools.
- the Framingham study produced a prediction equation for coronary heart disease (CHD) that has been widely used by physicians. This study is generally believed to be one of the best available prediction models.
- the disease prediction factors in the equation included age, blood pressure, smoking, cholesterol level, diabetes and ECG-left ventricular hypertrophy.
- the prediction equation has been estimated to account for about 60-70% of CHD among the general population.
- risk factors for CHD that were not included in the Framingham prediction equation. Examples of such risk factors that are not included are family history, plasma fibrinogen, serum C-reactive protein, serum albumin, leukocyte count, serum homocysteine and physical exercise.
- family history plasma fibrinogen, serum C-reactive protein, serum albumin, leukocyte count, serum homocysteine and physical exercise.
- One study reported that a single homocysteine measurement might be able to account for 10% of CHD risk.
- Y a 2 + b chol X 2 + b BM] X 3
- X is age
- X 2 is cholesterol level
- X 3 is BMI.
- Each individual b represents how much that factor (e.g., age) contributes to disease onset, as measured by that study. It is very difficult to combine these equations in any meaningful way to get an equation of the form:
- the present invention is directed to a method and apparatus for assessing a person's disease status by obtaining data on a plurality of disease prediction factors for that person, selecting a multivariate disease prediction equation for assessing disease status for a specified disease, and applying the multivariate disease prediction equation to the data to determine the disease status of that person.
- the multivariate disease prediction equation includes the contribution for each disease prediction factor that is included within a comprehensive set of disease prediction factors.
- a comprehensive set of disease prediction factors is used herein to refer to a set that includes most, if not all, of the disease prediction factors that are known to provide an independent and statistically significant contribution to a specified disease status.
- Each of the plurality of disease prediction factors for which data are available from the test person is included in the comprehensive set.
- the multivariate disease prediction equation is obtained by: (a) obtaining disease association data for each disease prediction factor in a first subset of the comprehensive set of disease prediction factors that are used in the multivariate disease prediction equation;
- Figure 2 shows a flow chart of a method for developing a multivariate disease prediction equation for determining disease status for a specified disease.
- the disease status for a person may be assessed by obtaining data on a plurality of disease prediction factors for the person and applying a multivariate disease prediction equation to that person's data wherein the multivariate disease prediction equation may be of the form of equation I,
- the future disease outcome may be expressed either in terms of the probability that the person will ever suffer from a specific disease outcome anytime in the future or in terms of the probability that the disease will occur within a specified time period in the future.
- the disease status Y may represent the probability that the test person currently has a specified disease, for example, low bone density, wherein diagnosis of the current condition is based on indirect measurements of risk factors correlated with the specified disease variable.
- a predicted value of the disease outcome variable for example, bone density, is obtained without necessarily measuring the outcome variable itself.
- the disease status may also be expressed as a predicted quantitative value of a specific outcome variable, for example, current or future high blood pressure.
- a specific outcome variable for example, current or future high blood pressure.
- Use of the term "predicted” in this context does not necessarily mean forecasting that a specified event will occur at some point in the future, but may also be used in a statistical sense in which a disease outcome variable is predicted to have a given value within a given confidence level based on combining indirect measurements of risk factors correlated with the specified disease variable. For example, using blood pressure as the outcome variable, one may predict what the measured blood pressure would be based solely on combining indirect measurements to arrive at a "predicted” blood pressure as distinct from directly measuring blood pressure.
- the present methodology provides a means for incorporating newly acquired disease association data with previously known disease association data so as to develop a continuously updated multivariate disease prediction equation that includes all the known or more reliable disease prediction factors. Since the newly acquired disease association data may be directed to disease prediction factors that are themselves correlated with the previously known disease prediction factors, the present methodology specifically includes a step that distinguishes between the contribution of the newly discovered disease prediction factor that was already inherently included in the existing disease prediction equation and the additional contribution that was not included in the previously existing equation.
- the newly acquired disease association data are directed to a newly discovered disease prediction factor having a very strong correlation with the known disease prediction factors, then very little additional information may be provided by the new data.
- the newly discovered disease prediction factor has very little correlation with any of the known disease prediction factors, a substantial additional contribution to a person's disease risk may be incorporated into the multivariate disease prediction equation whenever this newly discovered disease prediction factor is included in the equation.
- the present methodology provides a means for incorporating only the additional contribution of each newly discovered disease prediction factor. This is achieved by obtaining cross-correlation data between each of the disease prediction factors in the comprehensive set of disease prediction factors, the cross-correlation data being obtained from a database in which all the disease prediction factors in the comprehensive set are included; and using the disease association data together with the cross-correlation data to develop the multivariate disease prediction equation.
- the invented method not only estimates the simultaneous effect of smoking and vegetable intake on lung cancer risk but also the independent effect of smoking and vegetable intake when the other variable is controlled or compensated. Since the independent association of each risk factor with disease outcome is usually of primary interest in such studies, researchers will therefore be very interested in knowing how much the risk of lung cancer is accounted for by one factor while holding the other constant, or vice versa.
- One assumption underlying the invention is that the correlation among the independent variables, the "cross-correlation data," that are acquired from a third source is the same as, or at least similar to, the correlation among each individual study population from where the un ⁇ vanatten associations were derived. If the correlation among independent variables has some biological basis, this assumption will be met. For example, it is reasonable to assume that the correlation between blood pressure and obesity, the two independent risk factors for diabetes, are at least very similar across different populations. For this invention, the correlation information between the variables can be derived from some third source or empirical study.
- REGRESSION this term refers to the tendency c. .he outcome variable Y to vary with exposure variable X in a systematic fashion.
- GENERAL LINEAR REGRESSION this terms refers to a statistical method used for analyzing a linear relationship between a continuous outcome variable and a set of exposure variables.
- the outcome variable e.g., disease status
- continuous variables include, but are not limited to, blood pressure and cholesterol level.
- Variables like blood pressure can be considered measures of disease status, and so any model that uses these types of variables as outcome variables can be used to predict disease status.
- An example of a dichotomous variable i.e., a discontinuous variable . . .- . ' L. ... condition either exists or does not exist
- a disease onset event include a disease onset event.
- the outcome variable is a continuous variable like blood pressure.
- the matrix X and outcome vector Y discussed above, can be used to calculated the partial-regression coefficients b. It is these partial-linear-regression coefficients that represent the contribution of the various disease factors.
- BMI body-mass index
- subject 1 has systolic blood pressure of 120 and a cholesterol level of 160; subject 2 has a systolic blood pressure of 130 and a cholesterol level of 190.
- subject 1 has systolic blood pressure of 120, is 20 years old, and has a BMI of 21; subject 2 has a systolic blood pressure of 130, is 25 years old, and has a BMI of 25.
- the first blood pressure vs. cholesterol level equation is a univariate regression equation wherein b ch0 , is b u , and a, is a ul .
- the a ⁇ b ⁇ and b BMI in the second equation are not univariate regression coefficients, but with the data in Table 3, the univariate regression coefficients for age (b ⁇ ) and for BMI (b u3 ) can be derived along with the corresponding constant terms (a ⁇ and a u3 ).
- the three univariate regression equations can be expressed as follows:
- the correlation matrix is a symmetric matrix.
- the multivariate regression coefficients can be calculated to provide a disease prediction equation that includes each disease prediction factor.
- the regression coefficients for the equation can be calculated with the following general equation:
- b is a vector of all the partial regression coefficients, in the above example, b,, b 2 , and b 3 ;
- b u is the vector of all the univariate coefficients for each independent variable, in the above example, b ul , b ⁇ , and b ⁇ ;
- S is the vector of the standard deviation of each independent variable, in the above example, S,. S 2 , and S 3 ;
- the disease prediction factors cholesterol level, age and BMI are the independent variables, where b ul represents how cholesterol level is associated with systolic blood pressure, b ⁇ represents how age is associated with systolic blood pressure, and b u3 represents how BMI is associated with systolic blood pressure.
- the vector b which contains b,, b 2 , and b 3 in this example, is calculated.
- the entries of this vector represent the contribution of the disease factor X, with which b, is associated.
- This methodology may be extended to include all disease prediction factors for which the required correlation data are available, thus arriving at an equation of the form:
- the required correlation data include the disease association data as well as the cross-correlation data for all the disease prediction factors.
- This method applies to the situation where all the independent variables (disease prediction factors) are also dichotomous.
- this dependent variable is dichotomous, even though the probability P of getting hypertension, is continuous.
- smoking and alcohol drinking assume that there are only the following two factors for hypertension, and they are also dichotomous: smoking and alcohol drinking.
- prior art techniques in order to develop a multiple logistic equation it is necessary to have one study that measures hypertension status as a function of both risk factors (smoking and alcohol drinking). Assume for the purpose of the example that no such single study exists.
- b extra is calculated by subtracting b chol from b u . Once the subtraction is done, you end up with b extra .
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/277,257 US6110109A (en) | 1999-03-26 | 1999-03-26 | System and method for predicting disease onset |
US277257 | 1999-03-26 | ||
PCT/US2000/007956 WO2000057775A1 (en) | 1999-03-26 | 2000-03-24 | System and method for predicting disease onset |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1179990A1 true EP1179990A1 (en) | 2002-02-20 |
EP1179990A4 EP1179990A4 (en) | 2006-04-19 |
Family
ID=23060088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00921448A Withdrawn EP1179990A4 (en) | 1999-03-26 | 2000-03-24 | System and method for predicting disease onset |
Country Status (4)
Country | Link |
---|---|
US (1) | US6110109A (en) |
EP (1) | EP1179990A4 (en) |
HK (1) | HK1045000A1 (en) |
WO (1) | WO2000057775A1 (en) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7127290B2 (en) * | 1999-10-01 | 2006-10-24 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods predicting congestive heart failure status |
US6272377B1 (en) * | 1999-10-01 | 2001-08-07 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia prediction and prevention |
US7542913B1 (en) * | 2000-03-08 | 2009-06-02 | Careguide, Inc. | System and method of predicting high utilizers of healthcare services |
US6322504B1 (en) * | 2000-03-27 | 2001-11-27 | R And T, Llc | Computerized interactive method and system for determining a risk of developing a disease and the consequences of developing the disease |
WO2002014562A2 (en) | 2000-08-11 | 2002-02-21 | Dofasco Inc. | Desulphurization reagent control method and system |
CA2446526C (en) * | 2000-09-13 | 2013-11-19 | Richard A. Schmidt | Diagnosis of lower urinary tract dysregulation |
US20020128867A1 (en) * | 2000-12-29 | 2002-09-12 | Goetzke Gary A. | Chronic pain patient identification system |
US20020123906A1 (en) * | 2000-12-29 | 2002-09-05 | Goetzke Gary A. | Chronic pain patient risk stratification system |
US20030097185A1 (en) * | 2000-12-29 | 2003-05-22 | Goetzke Gary A. | Chronic pain patient medical resources forecaster |
US7043288B2 (en) | 2002-04-04 | 2006-05-09 | Inlight Solutions, Inc. | Apparatus and method for spectroscopic analysis of tissue to detect diabetes in an individual |
US7716069B2 (en) * | 2001-08-06 | 2010-05-11 | Ulrich Medical Concepts Inc | System and method for implementing medical risk algorithms at the point of care |
US7181054B2 (en) * | 2001-08-31 | 2007-02-20 | Siemens Medical Solutions Health Services Corporation | System for processing image representative data |
US20030101076A1 (en) * | 2001-10-02 | 2003-05-29 | Zaleski John R. | System for supporting clinical decision making through the modeling of acquired patient medical information |
WO2003033742A1 (en) * | 2001-10-17 | 2003-04-24 | University Of Utah Research Foundation | Methods for identifying differentially expressed genes by multivariate analysis of microarry data |
US7127096B2 (en) * | 2001-11-20 | 2006-10-24 | Accuimage Diagnostics Corp. | Method and software for improving coronary calcium scoring consistency |
JP4062910B2 (en) * | 2001-11-29 | 2008-03-19 | 株式会社日立製作所 | HEALTH MANAGEMENT SUPPORT METHOD AND DEVICE AND HEALTH LIFE LIFE PREDICTION DATA GENERATION METHOD AND DEVICE |
US8715194B2 (en) * | 2002-02-21 | 2014-05-06 | Regents Of The University Of Minnesota | Screening for early detection of cardiovascular disease in asymptomatic individuals |
US20040078232A1 (en) * | 2002-06-03 | 2004-04-22 | Troiani John S. | System and method for predicting acute, nonspecific health events |
US7149331B1 (en) * | 2002-09-03 | 2006-12-12 | Cedara Software Corp. | Methods and software for improving thresholding of coronary calcium scoring |
US20040059199A1 (en) * | 2002-09-04 | 2004-03-25 | Thomas Pamela Sue | Wound assessment and monitoring apparatus and method |
US20040242972A1 (en) * | 2003-05-28 | 2004-12-02 | General Electric Company | Method, system and computer product for prognosis of a medical disorder |
US20050032066A1 (en) * | 2003-08-04 | 2005-02-10 | Heng Chew Kiat | Method for assessing risk of diseases with multiple contributing factors |
WO2005020984A2 (en) * | 2003-08-29 | 2005-03-10 | Aaipharma Inc. | Method of reducing the risk of oxidative stress |
EP1681983A4 (en) * | 2003-10-14 | 2008-12-10 | Monogram Biosciences Inc | Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
US20050119534A1 (en) * | 2003-10-23 | 2005-06-02 | Pfizer, Inc. | Method for predicting the onset or change of a medical condition |
US20050222897A1 (en) * | 2004-04-01 | 2005-10-06 | Johann Walter | Method and system for improving at least one of a business process, product and service |
US7306562B1 (en) | 2004-04-23 | 2007-12-11 | Medical Software, Llc | Medical risk assessment method and program product |
US7676379B2 (en) * | 2004-04-27 | 2010-03-09 | Humana Inc. | System and method for automated extraction and display of past health care use to aid in predicting future health status |
US7555405B2 (en) * | 2004-09-30 | 2009-06-30 | John Antanies | Computerized method for creating a CUSUM chart for data analysis |
US7283928B2 (en) | 2004-09-30 | 2007-10-16 | John Antanies | Computerized method and software for data analysis |
US7957932B1 (en) | 2004-09-30 | 2011-06-07 | John Antanies | Data analysis systems and related methods |
US8195426B1 (en) | 2004-09-30 | 2012-06-05 | John Antanies | Data analysis systems and related methods |
KR100657901B1 (en) * | 2004-10-12 | 2006-12-14 | 삼성전자주식회사 | Method and apparatus of generating avata for representing state of health |
US20070055552A1 (en) * | 2005-07-27 | 2007-03-08 | St Clair David | System and method for health care data integration and management |
US7639782B2 (en) * | 2005-08-23 | 2009-12-29 | Ge Medical Systems Israel, Ltd. | Methods and systems for automatic patient table positioning |
WO2007067956A2 (en) * | 2005-12-07 | 2007-06-14 | The Trustees Of Columbia University In The City Of New York | System and method for multiple-factor selection |
US8234077B2 (en) * | 2006-05-10 | 2012-07-31 | The Trustees Of Columbia University In The City Of New York | Method of selecting genes from gene expression data based on synergistic interactions among the genes |
US8086409B2 (en) * | 2007-01-30 | 2011-12-27 | The Trustees Of Columbia University In The City Of New York | Method of selecting genes from continuous gene expression data based on synergistic interactions among genes |
US8504343B2 (en) * | 2007-01-31 | 2013-08-06 | University Of Notre Dame Du Lac | Disease diagnoses-bases disease prediction |
US8301233B2 (en) * | 2009-03-31 | 2012-10-30 | Medtronic, Inc. | Detecting a condition of a patient using a probability-correlation based model |
NL1037077C2 (en) * | 2009-06-26 | 2010-12-28 | Stichting Maastricht Radiation Oncology Maastro Clinic | SYSTEM FOR DETERMINING THE OPPORTUNITY FOR A POSSIBLE RESULT OF A MEDICAL TREATMENT. |
WO2012050969A1 (en) | 2010-09-29 | 2012-04-19 | Quentiq AG | Automated health data acquisition, processing and communication system |
US9378336B2 (en) | 2011-05-16 | 2016-06-28 | Dacadoo Ag | Optical data capture of exercise data in furtherance of a health score computation |
US8775218B2 (en) | 2011-05-18 | 2014-07-08 | Rga Reinsurance Company | Transforming data for rendering an insurability decision |
KR101855179B1 (en) * | 2011-12-21 | 2018-05-09 | 삼성전자 주식회사 | Optimal diagnosis factor set determining apparatus and method for diagnosing a disease |
WO2013192593A2 (en) * | 2012-06-21 | 2013-12-27 | Battelle Memorial Institute | Clinical predictive analytics system |
US20140073882A1 (en) * | 2012-09-12 | 2014-03-13 | Consuli, Inc. | Clinical diagnosis objects authoring |
US8636660B1 (en) | 2012-10-09 | 2014-01-28 | Regents Of The University Of Minnesota | System and method for dynamic multi-stage test administration for detection of cardiovascular disease |
WO2014145705A2 (en) | 2013-03-15 | 2014-09-18 | Battelle Memorial Institute | Progression analytics system |
WO2015017692A1 (en) | 2013-07-31 | 2015-02-05 | University Of Miami | Compositions and methods for identifying a risk of cancer in a subject |
US11462327B2 (en) | 2014-05-23 | 2022-10-04 | Dacadoo Ag | Automated health data acquisition, processing and communication system |
JP6520140B2 (en) * | 2015-01-22 | 2019-05-29 | Tdk株式会社 | Information processing apparatus, blood pressure value calculation method and program |
EP3380997A4 (en) | 2015-11-24 | 2019-09-11 | dacadoo ag | Automated health data acquisition, processing and communication system and method |
US10592554B1 (en) | 2017-04-03 | 2020-03-17 | Massachusetts Mutual Life Insurance Company | Systems, devices, and methods for parallelized data structure processing |
CN107767960A (en) * | 2017-09-13 | 2018-03-06 | 温州悦康信息技术有限公司 | Data processing method, device and the electronic equipment of clinical detection project |
JP6964562B2 (en) * | 2018-07-17 | 2021-11-10 | ヤフー株式会社 | Information processing equipment, information processing methods, and information processing programs |
US20200387805A1 (en) * | 2019-06-05 | 2020-12-10 | Optum Services (Ireland) Limited | Predictive data analysis with probabilistic updates |
US11645565B2 (en) | 2019-11-12 | 2023-05-09 | Optum Services (Ireland) Limited | Predictive data analysis with cross-temporal probabilistic updates |
CN115831306A (en) * | 2023-02-23 | 2023-03-21 | 北京康博众联电子科技有限公司 | Data analysis device and method and computer storage medium |
CN117542163B (en) * | 2024-01-10 | 2024-04-12 | 湖南迅卓实业有限公司 | Human body management monitoring system based on external monitoring equipment |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998035609A1 (en) * | 1997-02-14 | 1998-08-20 | Biomar International, Inc. | A system for predicting future health |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733354A (en) * | 1984-11-23 | 1988-03-22 | Brian Potter | Method and apparatus for automated medical diagnosis using decision tree analysis |
US5265244A (en) * | 1986-02-14 | 1993-11-23 | International Business Machines Corporation | Method and system for facilitating processing of statistical inquires on stored data accessible through a data access structure |
US5224035A (en) * | 1986-05-07 | 1993-06-29 | Teijin Limited | Method and apparatus for judging deformation of vertebral body |
US5083571A (en) * | 1988-04-18 | 1992-01-28 | New York University | Use of brain electrophysiological quantitative data to classify and subtype an individual into diagnostic categories by discriminant and cluster analysis |
US4975840A (en) * | 1988-06-17 | 1990-12-04 | Lincoln National Risk Management, Inc. | Method and apparatus for evaluating a potentially insurable risk |
US5862304A (en) * | 1990-05-21 | 1999-01-19 | Board Of Regents, The University Of Texas System | Method for predicting the future occurrence of clinically occult or non-existent medical conditions |
JP3231810B2 (en) * | 1990-08-28 | 2001-11-26 | アーチ・デベロップメント・コーポレーション | Differential diagnosis support method using neural network |
US5130936A (en) * | 1990-09-14 | 1992-07-14 | Arinc Research Corporation | Method and apparatus for diagnostic testing including a neural network for determining testing sufficiency |
JPH06509670A (en) * | 1991-04-29 | 1994-10-27 | インテル・コーポレーション | Neural network containing differential neurons |
AU3323293A (en) * | 1991-12-12 | 1993-07-19 | Horus Therapeutics, Inc. | Method for diagnosis osteopenia and determining its severity |
US5343390A (en) * | 1992-02-28 | 1994-08-30 | Arch Development Corporation | Method and system for automated selection of regions of interest and detection of septal lines in digital chest radiographs |
CA2155303C (en) * | 1993-02-09 | 2010-04-20 | Linda C. Burkly | Treatment for insulin dependent diabetes |
US5473537A (en) * | 1993-07-30 | 1995-12-05 | Psychresources Development Company | Method for evaluating and reviewing a patient's condition |
US5692501A (en) * | 1993-09-20 | 1997-12-02 | Minturn; Paul | Scientific wellness personal/clinical/laboratory assessments, profile and health risk managment system with insurability rankings on cross-correlated 10-point optical health/fitness/wellness scales |
JP3703858B2 (en) * | 1993-09-30 | 2005-10-05 | シスメックス株式会社 | Attribution discrimination device |
AU1837495A (en) * | 1994-10-13 | 1996-05-06 | Horus Therapeutics, Inc. | Computer assisted methods for diagnosing diseases |
US5687716A (en) * | 1995-11-15 | 1997-11-18 | Kaufmann; Peter | Selective differentiating diagnostic process based on broad data bases |
-
1999
- 1999-03-26 US US09/277,257 patent/US6110109A/en not_active Expired - Lifetime
-
2000
- 2000-03-24 EP EP00921448A patent/EP1179990A4/en not_active Withdrawn
- 2000-03-24 WO PCT/US2000/007956 patent/WO2000057775A1/en active Application Filing
-
2002
- 2002-08-13 HK HK02105903.3A patent/HK1045000A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998035609A1 (en) * | 1997-02-14 | 1998-08-20 | Biomar International, Inc. | A system for predicting future health |
Non-Patent Citations (2)
Title |
---|
ANDERSON K M ET AL: "An updated coronary risk profile. A statement for health professionals." January 1991 (1991-01), CIRCULATION. JAN 1991, VOL. 83, NR. 1, PAGE(S) 356 - 362 , XP008059658 ISSN: 0009-7322 * the whole document * * |
See also references of WO0057775A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000057775A1 (en) | 2000-10-05 |
HK1045000A1 (en) | 2002-11-08 |
EP1179990A4 (en) | 2006-04-19 |
US6110109A (en) | 2000-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6110109A (en) | System and method for predicting disease onset | |
Skates et al. | Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers | |
US7487134B2 (en) | Medical risk stratifying method and system | |
Ottenbacher et al. | A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions | |
US8793144B2 (en) | Treatment effect prediction system, a treatment effect prediction method, and a computer program product thereof | |
Lagani et al. | A systematic review of predictive risk models for diabetes complications based on large scale clinical studies | |
Curran et al. | Identifying the types of missingness in quality of life data from clinical trials | |
Bilgel et al. | Predicting time to dementia using a quantitative template of disease progression | |
Kleinbaum et al. | Maximum likelihood techniques: An overview | |
Morisot et al. | Prostate cancer: net survival and cause-specific survival rates after multiple imputation | |
Dempsey et al. | Survival models and health sequences | |
Laxy et al. | Performance of the UKPDS Outcomes Model 2 for predicting death and cardiovascular events in patients with type 2 diabetes mellitus from a German population-based cohort | |
Lin et al. | Deep learning for the dynamic prediction of multivariate longitudinal and survival data | |
D'Angelo et al. | An index approach for the Cox model with left censored covariates | |
Liu et al. | Estimating risk with time-to-event data: An application to the women’s health initiative | |
KR100935610B1 (en) | Ischemic heart disease risk prediction apparatus, method for the same, and computer readable recording medium on which program for the same is recorded | |
Dandis et al. | A tutorial on dynamic risk prediction of a binary outcome based on a longitudinal biomarker | |
JP2007526470A (en) | Method for predicting the state of gastric mucosa | |
Bhadra et al. | A Bayesian semiparametric approach for incorporating longitudinal information on exposure history for inference in case–control studies | |
Lundin et al. | Evaluation of a web-based system for survival estimation in breast cancer | |
Garber et al. | Predicting high-risk cholesterol levels | |
Stevenson | Statistical models for cancer screening | |
Garcia et al. | Statistical modeling of Huntington disease onset | |
McVittie et al. | Survival modelling for data from combined cohorts: opening the door to meta survival analyses and survival analysis using electronic health records | |
Plekhova et al. | Medical Instrument-Computer system for calculating the fatal outcome of cardiovascular diseases system for calculating the outcome of cardiovascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011025 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20011025;LT PAYMENT 20011025;LV PAYMENT 20011025;MK PAYMENT 20011025;RO PAYMENT 20011025;SI PAYMENT 20011025 |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7G 06F 19/00 A |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HU, GUIZHOU Inventor name: ROOT, MARTIN, M. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060307 |
|
17Q | First examination report despatched |
Effective date: 20070403 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1045000 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20111001 |